prs_id slug legacy_id legacy_model prswebprefix trait_code trait_name trait_type description cohort cohort_label method gwas_source reference_label reference_url snp_count p_value pseudo_r2 brier_score mse aauc aauc_ci effect_metric top_effect_1 top_effect_1_ci top_or_1 top_or_1_ci top_effect_2 top_effect_2_ci top_or_2 top_or_2_ci top_effect_5 top_effect_5_ci top_or_5 top_or_5_ci top_effect_10 top_effect_10_ci top_or_10 top_or_10_ci top_effect_25 top_effect_25_ci top_or_25 top_or_25_ci q1_vs_q2_effect q1_vs_q2_effect_ci q1_vs_q2_p_value q1_vs_q3_effect q1_vs_q3_effect_ci q1_vs_q3_p_value q1_vs_q4_effect q1_vs_q4_effect_ci q1_vs_q4_p_value nominally_significant reversed_effect_warning underpowered_warning upload_to_portal sex cases controls genome_build tuning_parameter weights_external_url weights_url phewas_download_url exclusion_download_url last_updated prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-05-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-05_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank Fixed threshold (5e-05) GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 25 0.014 0.00071299 0.0827 0.532 0.504-0.561 OR 1.34 0.584-3.07 1.34 0.584-3.07 1.1 0.575-2.09 1.1 0.575-2.09 1.12 0.74-1.69 1.12 0.74-1.69 1.24 0.926-1.66 1.24 0.926-1.66 1.23 0.994-1.51 1.23 0.994-1.51 0.971 0.728-1.29 0.838 1.36 1.04-1.77 0.0261 1.34 1.03-1.75 0.0322 True False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-enoc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-enoc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-ENOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-ENOC_P_5e-05_UKB_20200608 184.11 Endometrioid ovarian cancer Binary Endometrioid ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 98 0.74 3.99076e-05 0.0827 0.508 0.483-0.533 OR 0.716 0.239-2.15 0.716 0.239-2.15 0.569 0.239-1.35 0.569 0.239-1.35 0.681 0.409-1.13 0.681 0.409-1.13 1.05 0.768-1.43 1.05 0.768-1.43 0.944 0.757-1.18 0.944 0.757-1.18 1.11 0.846-1.45 0.455 1.21 0.929-1.58 0.157 1.05 0.796-1.38 0.742 False False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-epoc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-epoc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-05_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 111 0.96 0.00295605 0.0827 0.5 0.472-0.529 OR 1.13 0.463-2.76 1.13 0.463-2.76 1.1 0.575-2.09 1.1 0.575-2.09 1.21 0.809-1.8 1.21 0.809-1.8 1.14 0.846-1.54 1.14 0.846-1.54 1.08 0.872-1.34 1.08 0.872-1.34 0.941 0.722-1.22 0.65 0.858 0.655-1.12 0.266 1.01 0.779-1.31 0.94 False False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-hsoc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-hsoc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-HSOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-HSOC_P_5e-05_UKB_20200608 184.11 High-grade serous ovarian cancer Binary High-grade serous ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 116 0.00094 0.000753451 0.0826 0.543 0.516-0.57 OR 0.923 0.347-2.45 0.923 0.347-2.45 1.31 0.72-2.39 1.31 0.72-2.39 1.39 0.951-2.03 1.39 0.951-2.03 1.47 1.11-1.93 1.47 1.11-1.93 1.32 1.07-1.62 1.32 1.07-1.62 1.35 1.02-1.78 0.0369 1.23 0.926-1.64 0.152 1.58 1.2-2.08 0.001 True False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-ieoc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-05_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 219 0.016 0.00385697 0.0826 0.532 0.506-0.559 OR 2.39 1.24-4.61 2.39 1.24-4.61 1.64 0.946-2.83 1.64 0.946-2.83 1.3 0.879-1.92 1.3 0.879-1.92 1.24 0.926-1.66 1.24 0.926-1.66 1.3 1.06-1.6 1.3 1.06-1.6 1.12 0.846-1.48 0.427 1.2 0.907-1.58 0.204 1.44 1.11-1.89 0.00704 True False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-05_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 146 0.79 0.00164366 0.0827 0.51 0.483-0.538 OR 0.717 0.239-2.15 0.717 0.239-2.15 0.779 0.367-1.65 0.779 0.367-1.65 0.941 0.604-1.47 0.941 0.604-1.47 1.14 0.847-1.54 1.14 0.847-1.54 1.18 0.952-1.45 1.18 0.952-1.45 1.07 0.82-1.4 0.609 0.949 0.721-1.25 0.71 1.19 0.912-1.54 0.203 False False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-occc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-occc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-OCCC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-OCCC_P_5e-05_UKB_20200608 184.11 Ovarian clear cell cancer Binary Ovarian clear cell cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 100 0.14 0.0015819 0.0827 0.518 0.491-0.546 OR 1.34 0.584-3.07 1.34 0.584-3.07 1.2 0.647-2.24 1.2 0.647-2.24 1.48 1.02-2.15 1.48 1.02-2.15 1.29 0.966-1.72 1.29 0.966-1.72 1.06 0.852-1.31 1.06 0.852-1.31 1.34 1.02-1.76 0.033 1.15 0.868-1.51 0.334 1.24 0.939-1.63 0.13 False False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-phelan-sioc-p-5e-05-ukb-20200608 prsweb-phecode184-11-phelan-sioc-p-5e-05-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-05_UKB_20200608 P_5e-05 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-05_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank Fixed threshold (5e-05) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 207 0.0016 0.0031182 0.0826 0.539 0.512-0.565 OR 1.97 0.971-3.99 1.97 0.971-3.99 1.31 0.72-2.39 1.31 0.72-2.39 1.81 1.28-2.55 1.81 1.28-2.55 1.75 1.35-2.28 1.75 1.35-2.28 1.29 1.05-1.58 1.29 1.05-1.58 0.959 0.723-1.27 0.773 1.19 0.908-1.56 0.206 1.34 1.03-1.75 0.0289 True False False False Female 473 4723 GRCh37/hg19 P<=5e-05 2020-06-08 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-06-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-06_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank Fixed threshold (5e-06) GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 25 0.014 0.00071299 0.0827 0.532 0.504-0.561 OR 1.34 0.584-3.07 1.34 0.584-3.07 1.1 0.575-2.09 1.1 0.575-2.09 1.12 0.74-1.69 1.12 0.74-1.69 1.24 0.926-1.66 1.24 0.926-1.66 1.23 0.994-1.51 1.23 0.994-1.51 0.971 0.728-1.29 0.838 1.36 1.04-1.77 0.0261 1.34 1.03-1.75 0.0322 True False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-epoc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-epoc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-06_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 26 0.1 0.00357338 0.0827 0.532 0.506-0.557 OR 0.716 0.239-2.14 0.716 0.239-2.14 0.885 0.435-1.8 0.885 0.435-1.8 0.942 0.605-1.47 0.942 0.605-1.47 1.02 0.749-1.4 1.02 0.749-1.4 1.23 0.994-1.51 1.23 0.994-1.51 1.07 0.809-1.42 0.624 1.28 0.974-1.68 0.0766 1.37 1.05-1.8 0.021 False False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-ieoc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-06_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 54 3.8e-06 0.00257925 0.0824 0.566 0.538-0.594 OR 1.34 0.583-3.07 1.34 0.583-3.07 1.31 0.721-2.39 1.31 0.721-2.39 1.77 1.25-2.5 1.77 1.25-2.5 1.81 1.4-2.34 1.81 1.4-2.34 1.52 1.24-1.86 1.52 1.24-1.86 1.03 0.767-1.39 0.833 1.41 1.07-1.86 0.0162 1.74 1.33-2.28 5.45e-05 True False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-06_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 28 0.0054 0.00264586 0.0826 0.54 0.513-0.567 OR 1.97 0.971-4 1.97 0.971-4 2.19 1.34-3.57 2.19 1.34-3.57 1.62 1.13-2.32 1.62 1.13-2.32 1.41 1.07-1.87 1.41 1.07-1.87 1.24 1-1.52 1.24 1-1.52 1.14 0.861-1.5 0.365 1.17 0.884-1.54 0.277 1.36 1.04-1.78 0.0242 True False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-lsoc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-lsoc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-LSOC_P_5e-06_UKB_20200608 184.11 Low-grade serous ovarian cancer Binary Low-grade serous ovarian cancer UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 15 0.094 0.000114221 0.0827 0.521 0.493-0.547 OR 0.717 0.239-2.15 0.717 0.239-2.15 1.1 0.576-2.1 1.1 0.576-2.1 1.39 0.951-2.03 1.39 0.951-2.03 1.29 0.966-1.72 1.29 0.966-1.72 1.2 0.973-1.48 1.2 0.973-1.48 0.85 0.644-1.12 0.25 1.03 0.793-1.35 0.802 1.15 0.885-1.49 0.3 False False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-mcoc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-mcoc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-MCOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-MCOC_P_5e-06_UKB_20200608 184.11 Mucinous ovarian carcinoma Binary Mucinous ovarian carcinoma UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 27 0.89 0.00336535 0.0827 0.503 0.477-0.528 OR 1.76 0.839-3.7 1.76 0.839-3.7 1.53 0.871-2.69 1.53 0.871-2.69 1.21 0.809-1.8 1.21 0.809-1.8 0.884 0.636-1.23 0.884 0.636-1.23 0.955 0.766-1.19 0.955 0.766-1.19 0.979 0.75-1.28 0.877 1.03 0.789-1.34 0.841 0.959 0.733-1.25 0.76 False False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-phelan-sioc-p-5e-06-ukb-20200608 prsweb-phecode184-11-phelan-sioc-p-5e-06-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-06_UKB_20200608 P_5e-06 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-06_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank Fixed threshold (5e-06) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 58 2.6e-05 0.00323656 0.0825 0.556 0.529-0.584 OR 1.55 0.709-3.38 1.55 0.709-3.38 1.97 1.18-3.27 1.97 1.18-3.27 1.62 1.13-2.32 1.62 1.13-2.32 1.36 1.03-1.81 1.36 1.03-1.81 1.4 1.14-1.71 1.4 1.14-1.71 1.03 0.765-1.38 0.852 1.48 1.12-1.95 0.00539 1.63 1.24-2.14 0.000408 True False False False Female 473 4723 GRCh37/hg19 P<=5e-06 2020-06-08 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-07-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-07-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-07_UKB_20200608 P_5e-07 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-07_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank Fixed threshold (5e-07) GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 23 0.018 0.000777744 0.0827 0.531 0.502-0.559 OR 1.55 0.709-3.38 1.55 0.709-3.38 0.991 0.504-1.95 0.991 0.504-1.95 1.07 0.706-1.63 1.07 0.706-1.63 1.26 0.946-1.69 1.26 0.946-1.69 1.24 1.01-1.52 1.24 1.01-1.52 0.929 0.697-1.24 0.617 1.29 0.992-1.69 0.0574 1.31 1.01-1.71 0.0451 True False False False Female 473 4723 GRCh37/hg19 P<=5e-07 2020-06-08 prsweb-phecode184-11-phelan-epoc-p-5e-07-ukb-20200608 prsweb-phecode184-11-phelan-epoc-p-5e-07-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-07_UKB_20200608 P_5e-07 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-07_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-07) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 7 0.0084 0.00482005 0.0826 0.535 0.509-0.563 OR 1.29 0.562-2.94 1.29 0.562-2.94 1.42 0.813-2.49 1.42 0.813-2.49 1.45 1-2.1 1.45 1-2.1 1.36 1.03-1.8 1.36 1.03-1.8 1.24 1.01-1.53 1.24 1.01-1.53 1.26 0.959-1.65 0.0971 1.27 0.964-1.69 0.0891 1.46 1.12-1.91 0.00502 True False False False Female 473 4723 GRCh37/hg19 P<=5e-07 2020-06-08 prsweb-phecode184-11-phelan-ieoc-p-5e-07-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-p-5e-07-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-07_UKB_20200608 P_5e-07 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-07_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-07) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 23 7e-07 0.00383211 0.0823 0.567 0.539-0.595 OR 1.97 0.971-4 1.97 0.971-4 1.53 0.872-2.69 1.53 0.872-2.69 1.62 1.13-2.32 1.62 1.13-2.32 1.78 1.37-2.31 1.78 1.37-2.31 1.46 1.2-1.79 1.46 1.2-1.79 1.29 0.963-1.74 0.0875 1.51 1.14-2.02 0.00456 1.88 1.42-2.48 8.34e-06 True False False False Female 473 4723 GRCh37/hg19 P<=5e-07 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-p-5e-07-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-p-5e-07-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-07_UKB_20200608 P_5e-07 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-07_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank Fixed threshold (5e-07) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 13 0.0056 0.00546495 0.0826 0.542 0.516-0.569 OR 2.82 1.53-5.22 2.82 1.53-5.22 2.08 1.26-3.42 2.08 1.26-3.42 1.57 1.1-2.26 1.57 1.1-2.26 1.29 0.966-1.72 1.29 0.966-1.72 1.15 0.932-1.42 1.15 0.932-1.42 1.17 0.885-1.56 0.268 1.37 1.04-1.8 0.0236 1.37 1.04-1.8 0.0241 True False False False Female 473 4723 GRCh37/hg19 P<=5e-07 2020-06-08 prsweb-phecode184-11-phelan-sioc-p-5e-07-ukb-20200608 prsweb-phecode184-11-phelan-sioc-p-5e-07-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-07_UKB_20200608 P_5e-07 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-07_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank Fixed threshold (5e-07) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 31 4.5e-05 0.00399038 0.0825 0.547 0.518-0.575 OR 1.76 0.838-3.69 1.76 0.838-3.69 1.64 0.947-2.83 1.64 0.947-2.83 1.39 0.952-2.03 1.39 0.952-2.03 1.49 1.13-1.96 1.49 1.13-1.96 1.41 1.15-1.73 1.41 1.15-1.73 1.13 0.85-1.51 0.396 1.28 0.966-1.69 0.0862 1.61 1.23-2.1 0.000551 True False False False Female 473 4723 GRCh37/hg19 P<=5e-07 2020-06-08 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-09-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-09-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-09_UKB_20200608 P_5e-09 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-09_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank Fixed threshold (5e-09) GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 14 0.0042 0.000390947 0.0826 0.535 0.508-0.562 OR 1.13 0.463-2.77 1.13 0.463-2.77 0.99 0.504-1.95 0.99 0.504-1.95 1.25 0.844-1.86 1.25 0.844-1.86 1.26 0.946-1.69 1.26 0.946-1.69 1.21 0.984-1.49 1.21 0.984-1.49 1.18 0.885-1.57 0.26 1.47 1.11-1.93 0.0063 1.47 1.12-1.94 0.0059 True False False False Female 473 4723 GRCh37/hg19 P<=5e-09 2020-06-08 prsweb-phecode184-11-phelan-epoc-p-5e-09-ukb-20200608 prsweb-phecode184-11-phelan-epoc-p-5e-09-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-09_UKB_20200608 P_5e-09 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-09_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-09) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 5 0.0012 0.00222167 0.0826 0.544 0.516-0.572 OR 1.18 0.547-2.54 1.18 0.547-2.54 0.884 0.435-1.8 0.884 0.435-1.8 1.24 0.837-1.84 1.24 0.837-1.84 1.35 1.04-1.76 1.35 1.04-1.76 1.34 1.09-1.65 1.34 1.09-1.65 1.14 0.86-1.5 0.368 1.28 0.976-1.68 0.0741 1.52 1.18-1.96 0.00139 True False False False Female 473 4723 GRCh37/hg19 P<=5e-09 2020-06-08 prsweb-phecode184-11-phelan-ieoc-p-5e-09-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-p-5e-09-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-09_UKB_20200608 P_5e-09 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-09_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank Fixed threshold (5e-09) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 13 2e-06 0.00600953 0.0824 0.561 0.533-0.589 OR 1.34 0.585-3.08 1.34 0.585-3.08 1.42 0.796-2.54 1.42 0.796-2.54 1.53 1.06-2.21 1.53 1.06-2.21 1.57 1.2-2.06 1.57 1.2-2.06 1.51 1.23-1.84 1.51 1.23-1.84 1.09 0.813-1.47 0.554 1.42 1.07-1.89 0.0139 1.78 1.36-2.34 2.93e-05 True False False False Female 473 4723 GRCh37/hg19 P<=5e-09 2020-06-08 prsweb-phecode184-11-phelan-sioc-p-5e-09-ukb-20200608 prsweb-phecode184-11-phelan-sioc-p-5e-09-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-09_UKB_20200608 P_5e-09 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-09_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank Fixed threshold (5e-09) Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 19 1.5e-05 0.00442788 0.0824 0.549 0.52-0.579 OR 1.55 0.709-3.38 1.55 0.709-3.38 1.97 1.18-3.27 1.97 1.18-3.27 1.48 1.02-2.15 1.48 1.02-2.15 1.68 1.29-2.18 1.68 1.29-2.18 1.48 1.21-1.81 1.48 1.21-1.81 1.14 0.854-1.51 0.382 1.2 0.905-1.59 0.205 1.64 1.26-2.15 0.000257 True False False False Female 473 4723 GRCh37/hg19 P<=5e-09 2020-06-08 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-08-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-p-5e-08-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608 P_5e-08 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank GWAS Hits GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 21 0.017 0.00101702 0.0827 0.532 0.506-0.559 OR 0.923 0.347-2.45 0.923 0.347-2.45 0.99 0.504-1.95 0.99 0.504-1.95 1.07 0.706-1.63 1.07 0.706-1.63 1.12 0.827-1.51 1.12 0.827-1.51 1.15 0.932-1.42 1.15 0.932-1.42 1.04 0.784-1.39 0.776 1.38 1.05-1.8 0.019 1.29 0.987-1.7 0.0624 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000544/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000544/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_P_5e-08_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-epoc-p-5e-08-ukb-20200608 prsweb-phecode184-11-phelan-epoc-p-5e-08-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-08_UKB_20200608 P_5e-08 PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-08_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank GWAS Hits Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 6 0.0027 0.00348298 0.0826 0.544 0.517-0.573 OR 0.922 0.347-2.45 0.922 0.347-2.45 1.41 0.868-2.29 1.41 0.868-2.29 1.34 0.915-1.97 1.34 0.915-1.97 1.26 0.942-1.68 1.26 0.942-1.68 1.26 1.03-1.55 1.26 1.03-1.55 1.07 0.803-1.42 0.653 1.3 0.993-1.71 0.0564 1.54 1.17-2.03 0.00185 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000547/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000547/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-08_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-EPOC_P_5e-08_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-ieoc-p-5e-08-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-p-5e-08-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-08_UKB_20200608 P_5e-08 PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-08_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank GWAS Hits Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 16 1.1e-06 0.00558958 0.0824 0.567 0.539-0.595 OR 1.76 0.839-3.69 1.76 0.839-3.69 1.86 1.1-3.13 1.86 1.1-3.13 1.58 1.1-2.26 1.58 1.1-2.26 1.65 1.26-2.15 1.65 1.26-2.15 1.49 1.22-1.82 1.49 1.22-1.82 1.24 0.921-1.67 0.158 1.51 1.13-2.01 0.00473 1.86 1.41-2.46 9.74e-06 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000549/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000549/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-08_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_P_5e-08_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-p-5e-08-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-p-5e-08-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-08_UKB_20200608 P_5e-08 PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-08_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank GWAS Hits Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 10 0.00044 0.0036141 0.0825 0.556 0.53-0.584 OR 1.76 0.839-3.69 1.76 0.839-3.69 1.86 1.1-3.13 1.86 1.1-3.13 1.44 0.987-2.09 1.44 0.987-2.09 1.52 1.15-1.99 1.52 1.15-1.99 1.48 1.21-1.81 1.48 1.21-1.81 1.27 0.957-1.69 0.0968 1.24 0.934-1.66 0.136 1.71 1.31-2.25 9.9e-05 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000553/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000553/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-08_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_P_5e-08_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-sioc-p-5e-08-ukb-20200608 prsweb-phecode184-11-phelan-sioc-p-5e-08-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-08_UKB_20200608 P_5e-08 PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-08_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank GWAS Hits Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 21 8.4e-06 0.00501366 0.0824 0.552 0.523-0.581 OR 1.76 0.839-3.69 1.76 0.839-3.69 1.75 1.03-2.98 1.75 1.03-2.98 1.86 1.32-2.62 1.86 1.32-2.62 1.73 1.33-2.25 1.73 1.33-2.25 1.46 1.2-1.79 1.46 1.2-1.79 1.02 0.765-1.37 0.882 1.24 0.939-1.64 0.13 1.59 1.22-2.08 0.000581 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000560/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000560/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-08_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_P_5e-08_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-pt-ukb-20200608 prsweb-phecode184-11-gwas-catalog-r2019-05-03-x184-11-pt-ukb-20200608 PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_PT_UKB_20200608 184.11 Epithelial ovarian cancer;High-grade serous ovarian cancer;Serous invasive ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;Ovarian cancer in BRCA1 mutation carriers;Ovarian cancer;Ovarian clear cell cancer Binary 32 unique SNPs UKB UK Biobank P&T GWAS Catalog (2019-05-03) 19648919;21964575;23544013;25581431;28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=19648919+21964575+23544013+25581431+28346442 21 0.017 0.00101702 0.0827 0.532 0.506-0.559 OR 0.923 0.347-2.45 0.923 0.347-2.45 0.99 0.504-1.95 0.99 0.504-1.95 1.07 0.706-1.63 1.07 0.706-1.63 1.12 0.827-1.51 1.12 0.827-1.51 1.15 0.932-1.42 1.15 0.932-1.42 1.04 0.784-1.39 0.776 1.38 1.05-1.8 0.019 1.29 0.987-1.7 0.0624 True False False True Female 473 4723 GRCh37/hg19 P<=5e-08 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000545/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000545/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_PT_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_GWAS-Catalog-r2019-05-03-X184.11_PT_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-epoc-pt-ukb-20200608 prsweb-phecode184-11-phelan-epoc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-EPOC_PT_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 40 0.1 0.00482326 0.0827 0.526 0.5-0.554 OR 1.34 0.584-3.07 1.34 0.584-3.07 1.2 0.647-2.24 1.2 0.647-2.24 1.21 0.809-1.8 1.21 0.809-1.8 1.14 0.846-1.54 1.14 0.846-1.54 1.37 1.11-1.68 1.37 1.11-1.68 0.897 0.678-1.19 0.447 1.01 0.771-1.33 0.934 1.33 1.03-1.72 0.0315 False False False False Female 473 4723 GRCh37/hg19 P<=1e-05 2020-06-08 prsweb-phecode184-11-phelan-hsoc-pt-ukb-20200608 prsweb-phecode184-11-phelan-hsoc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-HSOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-HSOC_PT_UKB_20200608 184.11 High-grade serous ovarian cancer Binary High-grade serous ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 88 0.086 0.00192282 0.0827 0.523 0.494-0.551 OR 0.924 0.348-2.46 0.924 0.348-2.46 0.99 0.504-1.95 0.99 0.504-1.95 1.16 0.774-1.75 1.16 0.774-1.75 1.12 0.827-1.51 1.12 0.827-1.51 1.12 0.902-1.38 1.12 0.902-1.38 1.06 0.801-1.39 0.699 1.2 0.916-1.57 0.187 1.22 0.931-1.59 0.151 False False False False Female 473 4723 GRCh37/hg19 P<=3.98e-05 2020-06-08 prsweb-phecode184-11-phelan-ieoc-pt-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-IEOC_PT_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 12 8.6e-06 0.00654083 0.0824 0.558 0.53-0.586 OR 1.55 0.71-3.38 1.55 0.71-3.38 1.2 0.648-2.24 1.2 0.648-2.24 1.48 1.02-2.15 1.48 1.02-2.15 1.47 1.11-1.93 1.47 1.11-1.93 1.41 1.15-1.73 1.41 1.15-1.73 1.61 1.2-2.18 0.00172 1.72 1.28-2.31 0.000333 2.05 1.54-2.73 1.06e-06 True False False True Female 473 4723 GRCh37/hg19 P<=1.26e-09 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000551/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000551/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_PT_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_PT_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-pt-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-LSASBOC_PT_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 15 0.0099 0.00655237 0.0826 0.539 0.513-0.568 OR 2.18 1.11-4.3 2.18 1.11-4.3 2.08 1.26-3.42 2.08 1.26-3.42 1.77 1.25-2.5 1.77 1.25-2.5 1.39 1.05-1.84 1.39 1.05-1.84 1.21 0.984-1.49 1.21 0.984-1.49 1.13 0.849-1.49 0.408 1.31 0.993-1.72 0.0563 1.39 1.06-1.82 0.0172 True False False True Female 473 4723 GRCh37/hg19 P<=1.58e-06 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000555/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000555/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_PT_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_PT_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsoc-pt-ukb-20200608 prsweb-phecode184-11-phelan-lsoc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-LSOC_PT_UKB_20200608 184.11 Low-grade serous ovarian cancer Binary Low-grade serous ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 29 0.75 0.000711259 0.0827 0.503 0.475-0.531 OR 0.924 0.348-2.46 0.924 0.348-2.46 0.569 0.239-1.35 0.569 0.239-1.35 0.985 0.638-1.52 0.985 0.638-1.52 1 0.73-1.37 1 0.73-1.37 1.21 0.984-1.49 1.21 0.984-1.49 0.824 0.63-1.08 0.157 0.8 0.61-1.05 0.107 1.06 0.826-1.37 0.627 False False False False Female 473 4723 GRCh37/hg19 P<=1e-05 2020-06-08 prsweb-phecode184-11-phelan-mcoc-pt-ukb-20200608 prsweb-phecode184-11-phelan-mcoc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-MCOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-MCOC_PT_UKB_20200608 184.11 Mucinous ovarian carcinoma Binary Mucinous ovarian carcinoma UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 45 0.51 0.00531703 0.0827 0.51 0.481-0.538 OR 0.924 0.348-2.46 0.924 0.348-2.46 0.778 0.367-1.65 0.778 0.367-1.65 0.941 0.604-1.47 0.941 0.604-1.47 1.02 0.749-1.4 1.02 0.749-1.4 1.09 0.881-1.35 1.09 0.881-1.35 1.1 0.838-1.43 0.502 1.03 0.781-1.35 0.857 1.12 0.861-1.47 0.389 False False False False Female 473 4723 GRCh37/hg19 P<=1e-05 2020-06-08 prsweb-phecode184-11-phelan-occc-pt-ukb-20200608 prsweb-phecode184-11-phelan-occc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-OCCC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-OCCC_PT_UKB_20200608 184.11 Ovarian clear cell cancer Binary Ovarian clear cell cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 84 0.45 0.00276851 0.0827 0.51 0.482-0.538 OR 1.76 0.839-3.7 1.76 0.839-3.7 1.31 0.721-2.39 1.31 0.721-2.39 1.48 1.02-2.15 1.48 1.02-2.15 1.26 0.946-1.69 1.26 0.946-1.69 1.1 0.891-1.37 1.1 0.891-1.37 1.15 0.88-1.51 0.304 1.07 0.816-1.41 0.612 1.19 0.912-1.56 0.199 False False False False Female 473 4723 GRCh37/hg19 P<=3.98e-05 2020-06-08 prsweb-phecode184-11-phelan-sioc-pt-ukb-20200608 prsweb-phecode184-11-phelan-sioc-pt-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_PT_UKB_20200608 P&T PRSWEB_PHECODE184.11_Phelan-SIOC_PT_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank P&T Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 12 0.00023 0.00626094 0.0826 0.547 0.52-0.574 OR 0.511 0.142-1.84 0.511 0.142-1.84 1.31 0.721-2.39 1.31 0.721-2.39 1.25 0.845-1.86 1.25 0.845-1.86 1.29 0.966-1.72 1.29 0.966-1.72 1.37 1.11-1.68 1.37 1.11-1.68 1.55 1.15-2.07 0.00355 1.56 1.16-2.08 0.00303 1.86 1.4-2.47 1.69e-05 True False False True Female 473 4723 GRCh37/hg19 P<=6.31e-11 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000563/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000563/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_PT_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_PT_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-enoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-enoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-ENOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-ENOC_PRS-CS_UKB_20200608 184.11 Endometrioid ovarian cancer Binary Endometrioid ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 0.022 0.000440588 0.0827 0.526 0.498-0.554 OR 1.97 0.973-4 1.97 0.973-4 1.31 0.721-2.39 1.31 0.721-2.39 1.3 0.88-1.92 1.3 0.88-1.92 1.21 0.906-1.63 1.21 0.906-1.63 1.3 1.06-1.6 1.3 1.06-1.6 0.938 0.714-1.23 0.649 0.932 0.709-1.23 0.616 1.24 0.961-1.61 0.0974 True False False True Female 473 4723 GRCh37/hg19 auto https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000546/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000546/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-ENOC_PRS-CS_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-ENOC_PRS-CS_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-epoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-epoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-EPOC_PRS-CS_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 0.14 0.000555401 0.0827 0.516 0.488-0.546 OR 2.4 1.25-4.62 2.4 1.25-4.62 2.3 1.43-3.72 2.3 1.43-3.72 1.62 1.13-2.32 1.62 1.13-2.32 1.24 0.926-1.66 1.24 0.926-1.66 1.18 0.952-1.45 1.18 0.952-1.45 0.956 0.73-1.25 0.743 0.951 0.726-1.25 0.718 1.12 0.864-1.45 0.39 False False False False Female 473 4723 GRCh37/hg19 auto 2020-06-08 prsweb-phecode184-11-phelan-hsoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-hsoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-HSOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-HSOC_PRS-CS_UKB_20200608 184.11 High-grade serous ovarian cancer Binary High-grade serous ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 0.92 0.000338134 0.0827 0.503 0.475-0.532 OR 1.13 0.464-2.77 1.13 0.464-2.77 1.21 0.648-2.25 1.21 0.648-2.25 1.03 0.672-1.58 1.03 0.672-1.58 1.05 0.769-1.43 1.05 0.769-1.43 1.06 0.852-1.31 1.06 0.852-1.31 0.846 0.644-1.11 0.226 0.995 0.766-1.29 0.972 1.01 0.774-1.31 0.967 False False False False Female 473 4723 GRCh37/hg19 auto 2020-06-08 prsweb-phecode184-11-phelan-ieoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-IEOC_PRS-CS_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 2.3e-07 0.0119391 0.0823 0.568 0.542-0.595 OR 1.76 0.838-3.7 1.76 0.838-3.7 2.19 1.34-3.57 2.19 1.34-3.57 2.05 1.48-2.85 2.05 1.48-2.85 1.81 1.4-2.34 1.81 1.4-2.34 1.35 1.1-1.66 1.35 1.1-1.66 1.41 1.05-1.91 0.023 1.77 1.33-2.36 9.76e-05 1.88 1.42-2.5 1.35e-05 True False False True Female 473 4723 GRCh37/hg19 auto https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000550/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000550/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_PRS-CS_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_PRS-CS_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-LSASBOC_PRS-CS_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 0.032 0.00139645 0.0827 0.522 0.491-0.548 OR 3.92 2.27-6.79 3.92 2.27-6.79 2.65 1.68-4.18 2.65 1.68-4.18 1.44 0.988-2.09 1.44 0.988-2.09 1.21 0.906-1.63 1.21 0.906-1.63 1.14 0.922-1.41 1.14 0.922-1.41 0.987 0.751-1.3 0.925 1.05 0.803-1.37 0.718 1.15 0.88-1.49 0.312 True False False True Female 473 4723 GRCh37/hg19 auto https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000554/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000554/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_PRS-CS_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_PRS-CS_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-lsoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-LSOC_PRS-CS_UKB_20200608 184.11 Low-grade serous ovarian cancer Binary Low-grade serous ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115179 0.26 0.00169979 0.0827 0.504 0.477-0.533 OR 1.97 0.971-4 1.97 0.971-4 1.1 0.575-2.1 1.1 0.575-2.1 1.21 0.809-1.8 1.21 0.809-1.8 1.09 0.807-1.48 1.09 0.807-1.48 0.966 0.775-1.2 0.966 0.775-1.2 1.03 0.788-1.34 0.833 1.07 0.821-1.39 0.618 0.989 0.756-1.29 0.937 False False False False Female 473 4723 GRCh37/hg19 auto 2020-06-08 prsweb-phecode184-11-phelan-mcoc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-mcoc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-MCOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-MCOC_PRS-CS_UKB_20200608 184.11 Mucinous ovarian carcinoma Binary Mucinous ovarian carcinoma UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 0.26 0.000772542 0.0827 0.509 0.483-0.536 OR 2.4 1.25-4.63 2.4 1.25-4.63 1.75 1.03-2.99 1.75 1.03-2.99 1.25 0.845-1.86 1.25 0.845-1.86 1.19 0.886-1.6 1.19 0.886-1.6 1.15 0.932-1.42 1.15 0.932-1.42 0.898 0.687-1.17 0.431 0.867 0.662-1.14 0.3 1.05 0.808-1.35 0.735 False False False False Female 473 4723 GRCh37/hg19 auto 2020-06-08 prsweb-phecode184-11-phelan-occc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-occc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-OCCC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-OCCC_PRS-CS_UKB_20200608 184.11 Ovarian clear cell cancer Binary Ovarian clear cell cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115187 0.0039 0.00346787 0.0826 0.534 0.508-0.562 OR 1.55 0.71-3.38 1.55 0.71-3.38 1.75 1.03-2.98 1.75 1.03-2.98 1.53 1.06-2.2 1.53 1.06-2.2 1.39 1.05-1.84 1.39 1.05-1.84 1.38 1.13-1.7 1.38 1.13-1.7 0.975 0.736-1.29 0.859 1.08 0.822-1.43 0.571 1.41 1.09-1.83 0.00997 True False False True Female 473 4723 GRCh37/hg19 auto https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000557/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000557/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-OCCC_PRS-CS_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-OCCC_PRS-CS_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-sioc-prs-cs-ukb-20200608 prsweb-phecode184-11-phelan-sioc-prs-cs-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_PRS-CS_UKB_20200608 PRS-CS PRSWEB_PHECODE184.11_Phelan-SIOC_PRS-CS_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank PRS-CS Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1115189 8.9e-05 0.0158094 0.0825 0.552 0.526-0.58 OR 1.55 0.708-3.38 1.55 0.708-3.38 1.64 0.947-2.83 1.64 0.947-2.83 1.72 1.21-2.44 1.72 1.21-2.44 1.75 1.35-2.28 1.75 1.35-2.28 1.54 1.26-1.88 1.54 1.26-1.88 1.04 0.784-1.38 0.779 1.1 0.831-1.46 0.502 1.6 1.23-2.08 0.000444 True False False True Female 473 4723 GRCh37/hg19 auto https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000562/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000562/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_PRS-CS_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_PRS-CS_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-epoc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-epoc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-EPOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-EPOC_LASSOSUM_UKB_20200608 184.11 Epithelial ovarian cancer Binary Epithelial ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1441 0.01 0.00393675 0.0826 0.538 0.512-0.565 OR 1.13 0.463-2.77 1.13 0.463-2.77 1.1 0.576-2.1 1.1 0.576-2.1 1.34 0.915-1.97 1.34 0.915-1.97 1.31 0.987-1.75 1.31 0.987-1.75 1.24 1.01-1.52 1.24 1.01-1.52 1.06 0.796-1.4 0.705 1.28 0.977-1.68 0.0729 1.38 1.05-1.8 0.0194 True False False True Female 473 4723 GRCh37/hg19 s=0.5;Lambda=0.01438 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000548/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000548/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-EPOC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-EPOC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-hsoc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-hsoc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-HSOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-HSOC_LASSOSUM_UKB_20200608 184.11 High-grade serous ovarian cancer Binary High-grade serous ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 37433 0.35 0.00184855 0.0827 0.514 0.487-0.54 OR 0.923 0.347-2.45 0.923 0.347-2.45 1.1 0.574-2.09 1.1 0.574-2.09 1.21 0.81-1.8 1.21 0.81-1.8 1.22 0.906-1.63 1.22 0.906-1.63 1.07 0.862-1.32 1.07 0.862-1.32 1.07 0.817-1.41 0.617 1.1 0.838-1.44 0.499 1.13 0.861-1.47 0.388 False False False False Female 473 4723 GRCh37/hg19 s=1;Lambda=0.01438 2020-06-08 prsweb-phecode184-11-phelan-ieoc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-ieoc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-IEOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-IEOC_LASSOSUM_UKB_20200608 184.11 Invasive epithelial ovarian cancer Binary Invasive epithelial ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 41269 0.00028 0.0118842 0.0825 0.552 0.523-0.58 OR 1.97 0.97-3.99 1.97 0.97-3.99 1.75 1.02-2.98 1.75 1.02-2.98 1.48 1.02-2.15 1.48 1.02-2.15 1.44 1.09-1.9 1.44 1.09-1.9 1.4 1.14-1.71 1.4 1.14-1.71 1.09 0.815-1.45 0.573 1.26 0.954-1.66 0.103 1.6 1.22-2.09 0.000634 True False False True Female 473 4723 GRCh37/hg19 s=0.9;Lambda=0.01129 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000552/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000552/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-IEOC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsasboc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-lsasboc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSASBOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-LSASBOC_LASSOSUM_UKB_20200608 184.11 Low-grade serous and serous borderline ovarian cancer Binary Low-grade serous and serous borderline ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 486841 0.016 0.00512977 0.0826 0.516 0.489-0.544 OR 2.4 1.24-4.62 2.4 1.24-4.62 1.21 0.648-2.24 1.21 0.648-2.24 1.12 0.74-1.69 1.12 0.74-1.69 1.12 0.827-1.51 1.12 0.827-1.51 1.13 0.912-1.39 1.13 0.912-1.39 1.11 0.843-1.45 0.469 1.07 0.818-1.41 0.605 1.19 0.907-1.55 0.212 True False False True Female 473 4723 GRCh37/hg19 s=0.2;Lambda=0.008859 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000556/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000556/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSASBOC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-lsoc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-lsoc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-LSOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-LSOC_LASSOSUM_UKB_20200608 184.11 Low-grade serous ovarian cancer Binary Low-grade serous ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1635861 0.03 0.00399895 0.0826 0.498 0.471-0.527 OR 2.83 1.53-5.23 2.83 1.53-5.23 1.86 1.1-3.13 1.86 1.1-3.13 1.07 0.705-1.63 1.07 0.705-1.63 1.05 0.768-1.43 1.05 0.768-1.43 0.955 0.766-1.19 0.955 0.766-1.19 1.19 0.912-1.55 0.201 1.07 0.819-1.41 0.611 1.03 0.781-1.35 0.856 True False False False Female 473 4723 GRCh37/hg19 s=0.2;Lambda=0.005456 /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSOC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-LSOC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-mcoc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-mcoc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-MCOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-MCOC_LASSOSUM_UKB_20200608 184.11 Mucinous ovarian carcinoma Binary Mucinous ovarian carcinoma UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1467601 0.43 0.0027751 0.0827 0.507 0.48-0.534 OR 1.13 0.464-2.77 1.13 0.464-2.77 0.779 0.368-1.65 0.779 0.368-1.65 0.985 0.638-1.52 0.985 0.638-1.52 0.953 0.692-1.31 0.953 0.692-1.31 1.13 0.912-1.39 1.13 0.912-1.39 1.06 0.814-1.38 0.667 0.875 0.663-1.15 0.343 1.09 0.836-1.41 0.534 False False False False Female 473 4723 GRCh37/hg19 s=0.5;Lambda=0.006952 2020-06-08 prsweb-phecode184-11-phelan-occc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-occc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-OCCC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-OCCC_LASSOSUM_UKB_20200608 184.11 Ovarian clear cell cancer Binary Ovarian clear cell cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 1098236 5e-05 0.00981931 0.0824 0.546 0.52-0.574 OR 1.76 0.839-3.69 1.76 0.839-3.69 1.31 0.72-2.39 1.31 0.72-2.39 1.48 1.02-2.15 1.48 1.02-2.15 1.39 1.05-1.84 1.39 1.05-1.84 1.26 1.03-1.55 1.26 1.03-1.55 1.06 0.796-1.41 0.687 1.37 1.05-1.8 0.0225 1.45 1.1-1.89 0.00746 True False False True Female 473 4723 GRCh37/hg19 s=0.2;Lambda=0.006952 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000558/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000558/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-OCCC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-OCCC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08 prsweb-phecode184-11-phelan-sioc-lassosum-ukb-20200608 prsweb-phecode184-11-phelan-sioc-lassosum-ukb-20200608 PRSWEB_PHECODE184.11_Phelan-SIOC_LASSOSUM_UKB_20200608 Lassosum PRSWEB_PHECODE184.11_Phelan-SIOC_LASSOSUM_UKB_20200608 184.11 Serous invasive ovarian cancer Binary Serous invasive ovarian cancer UKB UK Biobank lassosum Phelan CM et al. 2017 28346442 https://www.ncbi.nlm.nih.gov/pubmed/?term=28346442 110710 4.9e-05 0.0151106 0.0825 0.556 0.529-0.583 OR 1.76 0.839-3.69 1.76 0.839-3.69 1.64 0.949-2.84 1.64 0.949-2.84 1.48 1.02-2.15 1.48 1.02-2.15 1.73 1.33-2.25 1.73 1.33-2.25 1.42 1.16-1.74 1.42 1.16-1.74 1.23 0.922-1.63 0.161 1.3 0.978-1.73 0.0707 1.68 1.28-2.2 0.000181 True False False True Female 473 4723 GRCh37/hg19 s=0.9;Lambda=0.01129 https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000564/ScoringFiles/ https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000564/ScoringFiles/ /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_LASSOSUM_UKB_20200608/all.tsv /larsf/prsweb-data/cancerprsweb/releases/cancerprsweb_20200608/phewas/PRSWEB_PHECODE184.11_Phelan-SIOC_LASSOSUM_UKB_20200608/exclusion.tsv 2020-06-08